Average Co-Inventor Count = 3.88
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gigagen, Inc. (15 from 21 patents)
2. Gigamune, Inc. (2 from 4 patents)
17 patents:
1. 12421311 - Anti-CTLA-4 binding proteins and methods of use thereof
2. 12404607 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof
3. 12241178 - Recombinant fusion proteins and libraries from immune cell repertoires
4. 12195880 - Systems and methods for massively parallel combinatorial analysis of single cells
5. 11718660 - Recombinant polyclonal proteins targeting Zika and methods of use thereof
6. 11702765 - Recombinant fusion proteins and libraries from immune cell repertoires
7. 11685779 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof
8. 11441240 - Systems and methods for massively parallel combinatorial analysis of single cells
9. 11427933 - Systems and methods for massively parallel combinatorial analysis of single cells
10. 11111490 - Systems and methods for massively parallel combinatorial analysis of single cells
11. 10689641 - Recombinant fusion proteins and libraries from immune cell repertoires
12. 10329557 - Systems and methods for massively parallel combinatorial analysis of single cells
13. 10214740 - Recombinant fusion proteins and libraries from immune cell repertoires
14. 9926554 - Recombinant fusion proteins and libraries from immune cell repertoires
15. 9926555 - Recombinant fusion proteins and libraries from immune cell repertoires